Status:
COMPLETED
Preoperative Speech Rehabilitation in Drug-Resistant Temporal Epilepsy: A Case Study
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Epilepsy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Out of 30,000 new cases per year in France, 30% of epileptic patients are drug-resistant. Neurosurgery, which consists in resecting the epileptogenic zone, is the only chance of cure. In the case of t...
Eligibility Criteria
Inclusion
- Patient of legal age,
- Patient with signed informed consent,
- Patient whose epileptogenic area involves the temporal structures of the hemisphere specialized for language,
- Patient with known hemispheric specialization for language (fMRI),
- Patient who is a surgical candidate and accepts resective surgery,
- Patient for whom a surgery date compatible with the study design has been set;
- Patient of French nationality and mother tongue (1st language learned by the patient),
- Patient affiliated to or benefiting from a social security system,
- Patient declaring to be familiar with the use of a computer and having access to an Internet connection from home.
Exclusion
- Pregnant or breastfeeding patients,
- Patients deprived of liberty,
- Patients under guardianship or curatorship
- Patients with speech disorders that may impair intelligibility and compromise the use of the interface,
- Patients with uncorrected hearing impairment,
- Patients with low overall intellectual functioning: total intelligence quotient (IQ) \<70 (data from the preoperative neuropsychological assessment performed in the year preceding the surgery)
Key Trial Info
Start Date :
September 20 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 2 2023
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT05325047
Start Date
September 20 2022
End Date
May 2 2023
Last Update
July 20 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Bordeaux
Bordeaux, France, 33000